Page last updated: 2024-10-29

ketanserin and Obsessive-Compulsive Disorder

ketanserin has been researched along with Obsessive-Compulsive Disorder in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, KH1
Hansen, ES1
Pinborg, LH1
Hasselbalch, SG1
Svarer, C1
Holm, S1
Bolwig, TG1
Knudsen, GM1

Trials

1 trial available for ketanserin and Obsessive-Compulsive Disorder

ArticleYear
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    The international journal of neuropsychopharmacology, 2005, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain Mapping; Caudate Nucleus; Female; Fluorine Rad

2005